In the States
CONNECTICUT: Attorney General Sues Eli Lilly
Over Alleged Illegal Marketing of Zyprexa More
CALIFORNIA: Rep. Feuer Introduces Bill Banning Drugmakers' Promotional Gifts Over $250 More
Delays Thwart Drug Tracking System More
MARYLAND: General Assembly Approves CareFirst Partnership for 'Doughnut Hole' Subsidy More
MASSACHUSETTS: Lawmakers Discuss Overhauling Payments to Physicians, Hospitals More
Canadian Drugs Reconsidered More
NEW HAMPSHIRE: Co-Pay Pricing Bill Supported by State Senate Committee More
NEW JERSEY: Informed Consent Moves Ahead More
CLASS ACTION: Florida, 18 States Sue Abbot Labs for Blocking Generic Prescription Competition More |
Book Review
Our Daily Meds: How the Pharmaceutical Companies Transformed Themselves into Slick marketing machines and Hooked the Nation on Prescription Drugs, By Melody Petersen
New York Times Book Review More
Interview with Melody Petersen More
|
Outrage of the WeekHospitals Increasingly Reviewing Patients' Personal Financial Information to Gauge Ability to Pay More |
Prices & Health Care Costs
Pricey Prescriptions: Ways to Cut Costs More
Rising Health Costs Cut Into Wages More
Payers Aim to Rein in Specialty-Drug Spending More
High Prescription Drug Prices Lead to Scrutiny of Medication Levels More
At $300,000 A Year, How Much Drug Is Too Much? More
How To Solve The Crisis Over Drug Prices More
GlaxoSmithKline Tests Sliding-Scale Prices More
Oncology Society Guidelines Address
Physicians Discussing Cost of Treatment Options More
|
Fraud & Abuse
Pfizer May Be Liable for Generic Neurontin Purchases in Class Action Suit More
McKesson Faces Big Damages Over AWP Lawsuit - Allegedly Inflated Prices for 400 Medicines More
CVS Agrees to Pay $37M to Settle Fraudulent Billing Claims for Heartburn Medication More
Former Biotech CEO Indicted on Fraud Charges More
Increase in Medicare, Medicaid Managed Care Plans Has Led to 'More Complex' Health Care Fraud More
|
Advertising & Marketing
Federal Legislation Would Shed Light on Relationship Between Drug Companies and Doctors More
'Academic Detailing' May Be Way to Provide
Unbiased Drug Data to Doctors, Senators Told More
Prescription Project Testimony Before US Senate Committee Supports Academic Detailing More
Free Drug Samples Hike Out-of-Pocket Costs More
Drug Companies on the Hook for Off-Label Use More
Inside Pharma: Online Ad Spending Sinking! More
Drug Sales Armies Beat Slow Retreat More
Ex-Drug Sales Rep Tells All More
Ex Pfizer Sales Manager Indicted for Alleged Obstruction off-Label Marketing Probe More
|
Confidentiality
Delays in Drug's Test Fuel Wider Data Debate More
Stolen Laptop Carried Personal Data from NIH Trial More
|
Pharma Watch
Report: U.S. Prescription Sales Grew 3.8 Percent in 2007, to $286.5 Billion More
FDA Is Approving Fewer New Molecular Entities More
Drug Makers Stick by China More
Merck Seeks to Expand Gardasil Market More
Plant Closed After Insulin Trials Stopped More
A Slow Year for Pharma - with a Few Exceptions More
|
Medicare
Vote on Budget Resolutions Without Proposed Spending Reductions for Medicare, Medicaid More
Baucus, Grassley Raise Concerns about Proposed Rule on Copays for Some Medicaid Beneficiaries More
Humana Cuts Forecast, Shares Tumble More
Christian Science Monitor Examines Florida Medicare Fraud Strike Force More
|
Medicaid
Drug Manufacturers Oppose Increasing
Medicaid Rebate in Mental Health Proposal More
Lawsuit Alleges West Virginia Fails To Comply With Medicaid Rule Filing Law More
Dingell Legislation Would Delay New Medicaid Regulations, Cutbacks, for One Year More
|
More Goings on in CongressLawmakers Ask GAO to Investigate
FDA's Lax Oversight of Clinical Trials More
Republicans Urge Examination Of Patent Reform's International Impact More
Senators Plan To Introduce Bill That Would Aim To Curb Pharmaceutical Industry 'Detailing' Practices More |
Generics & Patent Policy
Wal-Mart Says Generic Drug Discount Program Has Saved Consumers More than $1B More
House Bill to Allow FDA to Approve Generic Versions of Biotechnology Medications More
Generic Biotech Might Wait 14 More Years More
Washington Times Examines Results of Federal Investigation into Alleged Physician Kickbacks More
Drug Sales Growth at Lowest Rate Since 1961 More
Generics are manna for poor even in rich nations More
Drug Companies Push Anti-Generic Fears More
Keeping Generic Drugs off the Market More
A Drug By Any Other Name More
A Question of Values - Drug Patent Laws Must Have Public Health Exceptions More
|
Importation
McCain's Health 'Jihad' May Cost Pfizer, Doctors More |
Safety & Clinical Trials
FDA Moves to Allay Drug-Import Fears More
Not-for-Profit Group To Launch Web Site To Notify Physicians of Medication Label Changes, Warnings, Recalls More
Anti-Preemption Bill Would Reverse Decision More
FDA Setting Up Shop in China More
Doctors Learn Cancer Drug Can Damage Kidneys More
Zyprexa Judge: FDA Can't Police Safety Problems More
Heparin to be Blocked at Borders Unless Tested More
China Confirms Source of Heparin Contaminant More
China Requires Heparin Makers to Get Raw Material From Registered Suppliers More
|
Conflicts of Interest
Giving New Meaning to the Term "Unrestricted" More
Is Their Integrity on the Line When Doctors Pitch Products? More
|
